RemeGen Co., Ltd. (09995.HK/688331) Publishes November 2025 Share Capital Update

Bulletin Express12-02

RemeGen Co., Ltd. released its monthly return for the period ended November 30, 2025, detailing share capital movements for both its Hong Kong-listed H shares (stock code 09995) and Shanghai-listed A shares (stock code 688331).

According to the filing, the company’s H-share capital remained at 208,581,239 issued shares, with no change in treasury shares. Meanwhile, A-share capital increased by 102,000 shares, bringing the total to 355,129,004. The increase derived from the partial attribution of restricted shares under the 2022 A Share Incentive Scheme.

At month-end, total authorized or registered share capital stood at RMB563,710,243, comprising RMB208,581,239 for H shares and RMB355,129,004 for A shares. The filing confirmed there were no other warrant issuances, convertibles, or treasury share movements during the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment